Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 70
- Reported
- 68
- Verified
- 63
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Track; not yet
- Why
- Cost-per-genome ($80-$100) and scale (60k WGS/yr) are category-leading and real named customers (Regeneron/UK Biobank, Macrogen, Sanger) are deploying the UG-100 base, but the indel/homopolymer error profile, masked-genome regions, and Q2-2026 ship date for the new generation mean it is not yet an adopt-now substrate.
- Next
- Monitor Q2 2026 UG200 shipments and the first independent (non-Illumina) UG200/Solaris-2.0 WGS benchmark; revisit if a multi-omics partner needs population-scale low-cost WGS and homopolymer-region accuracy is non-critical.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 8
- Tier 1
- 1
- Tier 2
- 5
- Tier 3
- 2
- Supports
- 3
- Contradicts
- 2
- Context
- 3
- Latest observed
- 2026-02-01
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.